A recombinant Streptococcus lactis strain which carries the structural gene for a surface protein antigen (PAc) of 190,000 daltons from Streptococcus mutans serotype c was constructed for development of an oral vaccine against dental caries. The gene from S. mutans MT8148 joined to shuttle vector pSA3 was successfully transformed into S. lactis IL1403. A small amount of PAc was detected in the cell homogenate and cytoplasmic fraction of the recombinant S. lactis, but not in the culture supernatant of the recombinant, by Western immunoblotting and dot immunoblotting. The level of PAc-specific mRNA in the recombinant strain was lower than that in S. mutans MT8148. However, significant salivary immunoglobulin A and serum immunoglobulin G responses to PAc were induced in mice immunized orally with the recombinant S. lactis.
Streptococcus mutans has been strongly implicated as a causative organism of dental caries (7, 18) . S. mutans possesses a cell surface protein antigen of 190 kilodaltons that has been variously called antigen IIl (28) , B (29) , IF (10), P1 (6) , and PAc (26) . Here we refer to the 190-kilodalton protein antigen of S. mutans serotype c as PAc (26) . Okahashi et al. (26) and Lee et al. (14) have cloned the structural gene (pac) for the protein antigen. The complete nucleotide sequence of the gene for PAc has been recently determined (27) . Streptococcus sobrinus produces a protein antigen of 210 kilodaltons named SpaA (9) or PAg (25) which shows serological cross-reaction with PAc. The protein antigen gene of S. sobrinus has also been cloned (9, 23, 32) .
PAc has been successfully used as a vaccine to protect monkeys against dental caries (15, 17) . In addition, local passive immunization with monoclonal antibodies raised against PAc prevents the colonization by S. mutans of animal and human tooth surfaces (16, 19) .
Lactic streptococci have been used for a long time for production of dairy products such as yogurt and cheese, and frequent ingestion of a large number of viable bacterial cells by a great number of the population of the world is a well-known occurrence. On the basis of their safety, lactic streptococci might be one of the most suitable host organisms for oral vaccine production. Recently, protoplast transformation (12, 31) , electroporation (8) , and conjugal plasmid transfer (11) have become techniques available for introducing foreign DNA into lactic streptococci. Several Escherichia coli-Streptococcus lactis shuttle vectors have been constructed (3, 5, 35) for stable maintenance and expression of foreign genes in lactic streptococci.
Here we describe the introduction and expression of the pac gene in S. lactis by using an E. coli-S. lactis shuttle vector. Furthermore, we discuss whether the S. lactis producing recombinant PAc (rPAc) could be useful for the development of an oral vaccine against dental caries. 
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . S. lactis IL1403 and E. coli HB101 strains were kind gifts from Daniel van der Lelie (University of Groningen, Groningen, The Netherlands) and Keiji Yano (University of Tokyo, Tokyo, Japan), respectively. Plasmid pSA3 was a kind gift from Joseph J. Ferretti (University of Oklahoma, Oklahoma City, Okla.).
Reagents. All restriction enzymes used in this study were purchased from Toyobo Co. Ltd. (Osaka, Japan). T4 DNA ligase was from Takara Shuzo Co. (Kyoto, Japan). Horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) was from Bio-Rad Laboratories (Richmond, Calif.). Alkaline phosphatase-conjugated rabbit anti-mouse IgA, IgM, and IgG were from Zymed Laboratories Inc. (San Francisco, Calif.). Other reagents were of the highest purity commercially available.
PAc and antiserum. Native PAc was purified from the culture supernatant of S. mutans MT8148 grown in diffusate medium of brain heart infusion broth (Difco Laboratories, Detroit, Mich.). Rabbit anti-PAc serum was prepared as previously described (24) . The PAc was immunologically identical to antigen B kindly supplied by R. R. B. Russell (Royal College of Surgeons of England, Kent, England).
Construction of pSMl. The construction of the chimeric plasmid pPC41, containing the structural gene (pac) for PAc from S. mutans MT8148, was described previously (26) . This recombinant plasmid contains a 7.5-kilobase (kb) insert in pUC118 harboring the entire pac gene. The plasmid pPC41 was digested with SphI and BamHI to isolate the 6.2-kb fragment containing the pac gene (Fig. 1) . The fragment was then ligated to E. coli-S. lactis shuttle vector pSA3 that had been cleaved with the same enzymes. The ligated DNA was used to transform E. coli HB101 (20) . Transformants were selected on the basis of their anticipated antibiotic resistance phenotypes. Expression of the pac gene in recombinant E. coli cells was examined by colony immunoblotting with rabbit anti-PAc serum (26) . All clones that expressed rPAc harbored 16.4-kb chimeric plasmids, and one of these plasmids was termed pSM1. pSM1 plasmid DNA was prepared as previously described (20) . (20) with [32p] dCTP. Plasmid DNA from S. lactis and E. coli was digested with BamHI and SphI. The DNA fragments were separated by agarose gel electrophoresis and then transferred to nitrocellulose membranes (20) . After hybridization was completed, the filter was washed at 68°C in 0.1 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and subjected to autoradiography with Kodak X-Omat AR film (Eastman Kodak Co., Rochester, N.Y.) with overnight exposure at -800C.
Preparation of cell fractions of S. lactis and S. mutans. Lyophilized cells (0.7 g) were mixed with 10 g of glass beads (0.17 to 0.18 mm in diameter) and suspended in 10 ml of distilled water. The mixtures were homogenized 10 times for 1.5 min with a mechanical cell homogenizer (model MSK; B. Braun Apparatebau, Melsungen, Federal Republic of Germany). The homogenates contained cell walls and soluble materials (cell homogenate). The cell homogenate was further centrifuged at 10,000 x g for 20 min at 40C, and the supernatant was used as a cytoplasmic fraction. Dot immunoblotting assay. S. mutans and S. lactis were grown in brain heart infusion broth. Serial dilutions of culture supernatants and cytoplasmic fractions of S. mutans and S. lactis and PAc from the culture supernatant of S. mutans MT8148 were prepared in 50 mM Tris hydrochloride containing 0.15 M sodium chloride (pH 7.5; TBS). The samples (0.5 ml) were placed into wells of the 48-well BioDot SF microfiltration apparatus (Bio-Rad) with a sheet of nitrocellulose membrane and filtered through the membrane by gravity flow. Proteins on the membrane were fixed in 0.1 ml of 0.25% (vol/vol) glutaraldehyde for 15 min (30) . Free protein-binding sites were blocked by immersion in 0.1 M glycine in TBS for 10 min at room temperature. The nitrocellulose sheet was treated with rabbit anti-PAc serum. The antibody bound to the immobilized antigens on the sheet was detected by solid-phase immunoassay with horseradish peroxidase-conjugated goat anti-rabbit IgG (2). Quantitation of the color developed was done with an ACD-25-DX densitometer (Atto Co., Tokyo, Japan). The concentration of PAc in the samples was determined by comparison with a standard curve of known concentrations of PAc from the culture supernatant of S. mutans MT8148.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western immunoblot. Proteins were electrophoresed in 7.5% polyacrylamide gels as described by Laemmli (13) . The gels were stained with Coomassie brilliant blue or transferred to a nitrocellulose membrane by the electrophoretic blotting technique (2). After transfer, the membrane was treated with rabbit anti-PAc serum. The antibody bound to the immobilized replica proteins on the membrane was detected by solid-phase immunoassay with horseradish peroxidase-conjugated goat anti-rabbit IgG (2).
RNA dot blot. S. lactis and S. mutans were grown in 100 ml of Todd-Hewitt broth (Difco) supplemented with 20 mM DL-threonine. The cultures were grown to a concentration of approximately 109 cells per ml. The cells were harvested by centrifugation and suspended in 10 ml of brain heart infusion broth supplemented with 30% (wt/vol) raffinose. The cell suspensions were incubated with 2 mg of lysozyme per ml for 30 It was prehybridized and hybridized as described by Thomas (34) . The 1.5-kb PstI fragment of the pac gene, which covers the middle region of PAc, was radiolabeled as described above and used as the probe.
Estimation of plasmid stability. Strains of S. lactis and E. coli harboring plasmids were precultured overnight in GM17 broth and LB broth (20) containing erythromycin (5 ,ug/ml) and chloramphenicol (10 ,ug/ml), respectively. A 0.2-mi portion of overnight culture was seeded in 10 ml of medium with or without antibiotics. After overnight cultivation, the cultures were diluted 104-to 106-fold with sterile water and plated onto BL agar (Eiken Chemical Co., Tokyo, Japan, for S. lactis) or LB agar (for E. coli) plates. After replica plating of 100 colonies on the plates with or without antibiotics, the numbers of colonies which were resistant and sensitive to antibiotics were scored.
Oral immunization. Male BALB/c mice, 8 weeks old, were used. Before immunization, whole cells (109) of S. lactis IL1403(pSM1) and IL1403(pSA3) were suspended in 0.5 ml of 0.5% Formalin. Three consecutive daily intragastric immunizations were performed for groups of mice (eight or nine animals per group) with intubation needles. After 4 and 5 weeks, booster immunizations were done with the same antigens. One week after the last challenge, saliva and serum samples were collected. Mice were anesthetized intraperitoneally with pentobarbital, and pilocarpine-stimulated saliva and blood were subsequently collected. After clotting of the blood, serum was collected by centrifugation. These samples were stored at -70°C until use and were assayed by enzymelinked immunosorbent assay (ELISA) for their titers of PAcspecific antibodies (36). Serial twofold dilutions of samples were incubated in ELISA plates coated with PAc purified from the culture supernatant of S. mutans MT8148. The plates were subsequently treated with alkaline phosphataseconjugated rabbit anti-mouse IgA, IgM, or IgG antibodies for the determination of titer of PAc-specific IgA, IgM, or IgG, respectively, followed by addition of p-nitrophenylphosphate substrate solution. The ELISA antibody titer was as molecular weight markers. Lanes 1, 2, and 3, Cesium chloridepurified plasmid DNA of pSM1 from S. lactis IL1403, pSM1 from E. coli HB101, and pSA3 from E. coli HB101, respectively; lanes 4 and 5, BamHI-and SphI-digested pSM1 DNA from S. lactis IL1403 (pSM1) and E. coli HB101, respectively; lanes 6, pSA3 from E. coli HB101 digested with BamHI and SphI; lanes 7, pPC41 digested with BamHI and SphI.
expressed as the reciprocal, log2 unit, of the highest dilution giving an optical density at 405 nm of 0.1 after development for 1 h (serum) or 16 h (saliva) at room temperature.
Statistical analysis. Statistical comparison was performed by using Student's t test. Differences from the control values were considered significant if the P value was <0.05.
RESULTS
Construction of pSM1. The chimeric plasmid pPC41 contains the entire structural gene for PAc from S. mutans MT8148 (26) . A BamHI-SphI fragment of pac gene, lacking the 3'-terminal portion which presumably codes for the membrane anchor domain of PAc (27) , was inserted between the SphI and BamHI sites of an E. coli-S. lactis shuttle vector, pSA3, to inactivate its tetracycline resistance (Tcr) gene (Fig. 1) . The resultant chimeric plasmid pSM1 thus contained the pac gene, the erythromycin resistance (Emr) gene, and the chloramphenicol resistance (Cmr) gene.
Transformation of S. lactis IL1403 by the plasmid pSM1. S. lactis IL1403 was transformed with pSM1 by the protoplast transformation method described by Simon et al. (31) . Although the transformation efficiency in this study was lower than that reported by Simon et al. (31) , over 20 Emr transformants were obtained. All transformants tested harbored a single plasmid identical to pSM1 by agarose gel electrophoresis patterns (data not shown).
Southern blot analysis of pSM1 isolated from E. coli and S.
lactis. The plasmid isolated from S. lactis IL1403 harboring pSM1 was digested with BamHI and SphI. The digestion generated two fragments of 6.2 and 10.4 kb ( Fig. 2A, lane 4) . The restriction fragments were subjected to Southern blotting and hybridized with the radiolabeled BamHI-SphI fragment of pPC41 containing the pac gene. fragment hybridized to the probe (Fig. 2B) . The restriction and hybridization patterns of pSM1 from S. lactis IL1403 (pSMl) were the same as those of pSM1 isolated from E. coli. Expression of the pac gene in S. lactis. The amount of PAc produced by S. lactis IL1403(pSM1) and S. mutans MT8148 was measured with dot immunoblotting with anti-PAc antibody. A large amount of the antigen was detected in culture supernatant and cell homogenate of S. mutans MT8148 (Table 2) . A small amount of rPAc was detected in the cell homogenate of S. lactis IL1403(pSMl) but not in the culture supernatant of the recombinant organism. Cell homogenates and cytoplasmic fractions of S. lactis IL1403 and IL1403 (pSMl) were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. PAc was not found in the cell homogenate and cytoplasmic fraction of S. lactis IL1403 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting (Fig. 3) . A small amount of 190-kilodalton rPAc was detected in the cell homogenate and cytoplasmic fraction of S. lactis IL1403 (pSM1) (Fig. 3) .
Transcription transcription level of the pac gene in the recombinant S. lactis, the amount of PAc-specific mRNA was measured by RNA dot blot analysis with the radiolabeled 1.5-kb PstI fragment of the pac gene. The level of PAc-specific mRNA in S. lactis IL1403(pSM1) was four to eight times lower than that in S. mutans MT8148 (Fig. 4) . This result indicates that the poor expression of the pac gene in S. lactis IL1403 (pSM1) might be attributed to the poor transcription level of the gene in the host cell.
Stability of pSM1. The stability of pSM1 in S. lactis IL1403 was investigated after cultivation of the recombinant organism with or without 5 ,ug of erythromycin per ml for 24 or 48 h. The plasmid pSM1 as well as the vector pSA3 were relatively stable in S. lactis IL1403 in the presence of 5 ,ug of erythromycin per ml (Table 3) . Only 2 to 3% of the total clones lost resistance to erythromycin, while 22 to 28% of the clones lost resistance in the absence of erythromycin. These results suggest that poor production of rPAc by S. lactis IL1403(pSM1) was not likely because of the loss of plasmids during cultivation with erythromycin.
Immunization of mice with the recombinant S. lactis. Although the expression level ofpac in S. lactis IL1403(pSM1) was lower than that in S. mutans MT8148, the recombinant organism was effective in inducing PAc-specific antibodies in mice when given intragastrically. The immunization schedule is shown in Fig. 5 . Tables 4 and 5 show the production of PAc-specific immunoglobulins in mice immunized with the recombinant organism. Mice immunized with Formalinkilled recombinant cells (109) induced significant salivary IgA and serum IgG responses to PAc. DISCUSSION S. lactis has been safely used for food fermentation throughout history. The organism, therefore-, might be one of the most suitable hosts for oral vaccine production. In this study, we constructed an S. lactis strain producing an exogenous protein, a surface protein antigen (PAc) of S. mutans, for development of an oral vaccine against dental caries. Recently, Curtiss et al. (4) have also constructed r-ecombinant Salmonella typhimurium strains expressing a surface protein antigen (SpaA) of S. sobrinus for oral immunization.
Formalin-killed whole cells of S. lactis IL1403(pSM1) proved an effective immunogen in mice. Oral administration of the recombinant (109 cells) induced salivary IgA response to PAc. Salivary IgA is reported to act as a protective agent against dental caries in experimental animals (22) . Thus, the recombinant organism is expected to-be useful in oral vaccination against dental caries. Moreover, the recombinant organism was able to induce serum IgG responses to PAc, suggesting that the recombinant organism was also effective in inducing systemic immune response. Challenge studies with S. mutans in the presence of high levels of sucrose to measure colonization or caries prevention are in progress.
The 3'-truncated pac gene of S. mutans was expressed in S. lactis IL1403. However, the amount of rPAc in the cell homogenate of the recombinant strain was about sixfold smaller than that in the fraction of S. mutans MT8148. The S. mutans-derived DNA fragment used in this study contains the DNA sequence approximately 1.7 kilobase pairs upstream from the initiation codon of the pac (27) . Transcription of the pac gene may be controlled by this putative promoter sequence that might not work effectively in S. lactis. In fact, the amount of PAc-specific mRNA was smaller than that of the wild-type PAc producer. Lack of 207 base pairs and 69 amino acids at the 3'-and C-terminal ends, respectively, might also cause inefficient transcription, and with the resultant immature mRNA, translation might also be inefficient. Whether the poor production of rPAc in the recombinant strain is due to promoter inefficiency or to the lack of a 3' end may be elucidated by measuring the promoter strength in S. lactis in the future.
PAc is known to exist both in a form apparently closely associated with peptidoglycan of S. mutans strains and in their culture supernatants (21, 24, 29) . Because S. lactis IL1403(pSM1) was assumed to produce the protein antigen lacking the anchor domain, we expected that most of the antigen would be produced extracellularly. However, PAc was not found in the culture supernatant, although pSM1 had a putative 5' signal sequence of the pac gene (27) . At present, there is no satisfactory explanation for this finding.
Experimental and manufacturing guidelines for organisms containing recombinant genes to be taken orally in viable form have yet to be established. Therefore, we used the recombinant organism killed with Formalin in our immunization experiments. Even after being killed, the organism had enough antigenic activity to induce specific immunoglobulin production in mice via the oral immune system. The potency of this recombinant organism as an oral vaccine when administered in viable form will be evaluated in the future.
